Get the app today! Download iPhone App Download Android App

GlaxoSmithKline Announces 'Strategic Review' Of Horlicks Brand

Published on Mar 29 2018 8:48 AM in A-Brands tagged: Featured Post / India / GSK / GlaxoSmithKline / Paywall / Horlicks

GlaxoSmithKline Announces 'Strategic Review' Of Horlicks Brand

GlaxoSmithKline is to undertake a 'strategic review' of its Horlicks brand, as well as its other consumer healthcare nutrition products, to support funding for the purchase of Novartis' stake in a Consumer Healthcare Joint Venture.

GSK said that it has reached agreement with Novartis for the 36.5% stake, which is valued at $13 billion.

The Consumer Healthcare Joint Venture was formed as part of a three-part transaction between GSK and Novartis, which was approved by shareholders in 2014.

please subscribe or sign in to continue reading

image description

Try European Supermarket Magazine PREMIUM – 30 Day FREE Trial.

A trial subscription gives unrestricted access to all premium site content, app content, weekly email content and European Supermarket Magazine digital edition for a full 30 days. Try it now!

Share on Facebook Share on Twitter Share on LinkedIn Share via Email